DR. B. LAL CLINICAL LABORATORY UNVEILS NEW BLOOD TESTS

TACROLIMUS, BLOOD

“Tacrolimus takes care of your Organ Transplantation and its Management.”

A person's life may be saved or completely changed through a transplant. In 2021, more than 40,000 transplants were performed.

Clinical Significance of Tacrolimus, Blood

• This test is used for the quantitative determination of Tacrolimus (an immunosuppressive drug) in human whole blood in order to establish a dosing regimen, maintain therapeutic levels, and detect toxicity levels.
• If the concentration is too high, the patient may have signs of toxicity; if it is too low, organ rejection may occur.

Complications:

• Electrolyte disturbances, such as Hyperkalemia 
• Tinnitus - intermittent and/or persistent ringing or roaring in the ears
• Seizures

Test Detail

Test Name: Tacrolimus, Blood

Sample Type: EDTA, Blood

TAT: 6 hours

Method: Chemiluminescent Microparticle immunoassay (CMIA)

 

ALDOSTERONE

“Monitoring Aldosterone level can help in better management of HYPERTENSION.”

Globally, there are over 580 million people with hypertension who were never diagnosed, with 41% of women and 51% of men being unaware of their disease. Hypertension significantly raises the risk of renal, heart, and brain problems.

Clinical Significance of Aldosterone

• To diagnose and plan proper treatment for hypertension.
• Primary aldosteronism (Conn’s syndrome, which further includes adrenal adenoma/carcinoma and adrenal cortical hyperplasia),
• Secondary aldosteronism (renovascular disease, salt depletion, potassium loading, cardiac failure with ascites, pregnancy, and Bartter syndrome), 
• Adrenal insufficiency (Addison’s disease). 
• Identify endocrine disorders that can lead to fluid and electrolyte abnormalities brought on by certain kidney illnesses, cardiac issues, and adrenal disease.

Test Detail

Test Name: Aldosterone

Sample Type: Serum/Plasma/ 24- hour Urine

TAT: 6 hours

Method: Chemiluminescent Microparticle immunoassay (CMIA)

 

THYROCALCITONIN (CALCITONIN)

“Calcitonin screening has proven to be effective in the early Diagnosis & Recurrence of Medullary Thyroid Cancer”

The prognosis is the chance of recovery. However, medullary thyroid cancer can eventually move to the liver, lungs, bone, brain and it can also affect other neck tissues if it is left untreated.

Clinical Significance of Calcitonin

• To detect effectiveness of treatment & to monitor patients for recurrence C-cell hyperplasia: a benign condition that causes abnormal growth of cells in the thyroid. It might or might not develop into medullary thyroid carcinoma.
• Diagnosis and follow-up of Medullary Thyroid Carcinoma which is a malignant – it can spread beyond the thyroid and can be difficult to treat if it is not discovered early.
• To screen Medullary Thyroid Cancer (MTC) in family members of patients with Multiple Endocrine Neoplasia Type 2 (MEN 2) & Familial Medullary Thyroid Carcinoma.

 

Test Detail

Test Name: Thyrocalcitonin (Calcitonin)

Sample Type: Serum

TAT: 6 hours

Method: Chemiluminescent Microparticle immunoassay (CMIA)

 

TSH RECEPTOR ANTIBODY

“Early diagnosis of Graves’ disease & autoimmune thyroid disease can prevent severe complications.”

About 1 in 200 people have Graves' illness. Men can also have it, however women under the age of 40 are most commonly affected. An estimated 2 to 3 percent of people worldwide are impacted by it.

Clinical significance of TSH Receptor Antibody

• An aid in the differential diagnosis of Graves’ disease & detects recurrence of Graves’ hyperthyroidism.
• To predict the presence of thyroid autoimmunity. The thyroid is then stimulated by TSH receptor antibodies to produce too much thyroid hormone.
• Detects the risk of neonatal thyrotoxicosis in pregnant women with a past or current history of active Graves’s disease.
• Predict the risk of thyroid illness in neonates measuring the TSH receptor antibody in the final trimester of pregnancy in a patient with a history of thyroid disease.

 

Test Detail

Test Name: TSH Receptor Antibody

Sample Type: Serum

TAT: 6 hours

Method: Chemiluminescent Microparticle immunoassay (CMIA)

 

INSULIN ANTIBODY

“The starting point for living well with diabetes is an early diagnosis”

According to WHO, about 422 million people worldwide have diabetes; both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades. The most common is Type 2 diabetes. The incidence of Type 2 diabetes has significantly increased during the last three decades. Diabetes Type 1 (previously referred to as juvenile diabetes or insulin-dependent diabetes) is a chronic illness in which the pancreas makes little or no insulin on its own. 

Clinical significance of Insulin Antibody

• This assay quantitatively measures serum autoantibodies to endogenous insulin or antibodies to exogenous insulin. 
• In Insulin-dependent diabetes mellitus (IDDM) these antibodies tend to appear during the asymptomatic period (lasting anywhere from years to decades) which characterizes the disease, increasing their potential for early disease detection. 
• Insulin autoantibodies have been shown to be present in up to 50% IDDM patients at onset in children & are infrequent in diabetes presenting after puberty and even rarer in adults.
• Evaluating diabetes with insulin resistance in patients with diabetes (Type 1 or Type 2).

 

Test Detail

Test Name: Insulin Antibody

Sample Type: Serum

TAT: 6 hours

Method: Chemiluminescent Microparticle immunoassay (CMIA)

Now, you can book these tests at Dr. B. Lal Clinical Lab through a health app, website or call us on +91 9166125555 for home collection. You can also visit any of our nearest centers for blood testing.